Q2:2026 Business Update and Financial Results July 29, 2026 Nasdaq: IONS 1 On Today's Earnings Call Brett Monia, Ph.D. Chief Executive Officer Eugene Schneider, M.D. Chief Clinical Development Officer 2 Holly Kordasiewicz, Ph.D. Chief Development Officer Eric Swayze, Ph.D. Executive Vice President, Research Forward-Looking Statements This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial potential of our commercial medicines, addit ...